Daejeon City to Start COVID-19 Vaccinations Next Month... Establishing Response System

City to start AstraZeneca vaccine vaccinations next month
Janssen and Moderna vaccines in Q2, Pfizer vaccine in Q3
Plan to complete vaccinations for 1.23 million people aged 18+ by November
Vaccinations begin with 690,000 healthcare workers and elderly... gradual expansion

Daejeon City announced on the 19th that it will begin COVID-19 vaccinations starting next month. The first vaccine available for administration in the region is AstraZeneca. Photo by Yonhap News

[Asia Economy (Daejeon) Reporter Jeong Il-woong] Daejeon City will begin COVID-19 vaccination starting next month. Ahead of the vaccination, the city is establishing a response system to minimize confusion and side effects at the vaccination sites.

The city announced on the 19th that, in accordance with the government's vaccine supply schedule, it will start with the AstraZeneca vaccine next month, followed by the Janssen and Moderna vaccines in the second quarter, and the Pfizer vaccine in the third quarter, aiming to complete vaccinations by November.

The target vaccination population is 1.23 million people aged 18 and over. Following the guidelines of the Korea Disease Control and Prevention Agency, the city plans to prioritize vaccination for about 690,000 recommended groups, including medical personnel, workers in group facilities, the elderly, and staff at educational and childcare facilities, before gradually expanding the number of vaccinated individuals.

Before the full-scale vaccination begins, the city recently established the "COVID-19 Vaccination Promotion Team and Consultative Body" to support the vaccination system.

First, the Promotion Team is led by the Deputy Mayor and operates around four main teams: the Implementation General Team, Vaccine Supply Team, Vaccination Institution Management Team, and Adverse Reaction Management Team.

In their respective roles, the Implementation General Team oversees the establishment and execution of vaccination plans, supports vaccination plans in autonomous districts, and manages various consultative bodies related to the vaccination project.

The Vaccine Supply Management Team surveys vaccine demand by institution, adjusts accordingly, and manages and monitors the vaccine supply status. The Vaccination Institution Management Team designates and manages vaccination centers, inspects the layout of vaccination center facilities, and oversees the on-site operations of entrusted medical institutions.

The Adverse Reaction Management Team is responsible for managing adverse reactions following vaccination and promoting compensation in case of any damages.

Alongside the operation of the Promotion Team, the city has formed a separate consultative body to facilitate flexible cooperation with related associations such as the local medical association and nursing association.

The consultative body will focus on operating a communication system on-site through medical personnel support, rapid response cooperation in case of adverse reactions, and medical consultation.

Jung Hae-gyo, Director of the City’s Health and Welfare Bureau, stated, “We will establish a close cooperative system with related organizations such as the city-district policy council and public health centers to ensure that COVID-19 vaccinations proceed smoothly without any setbacks.”

This content was produced with the assistance of AI translation services.